In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolates

被引：28
|
作者：
Garcia-Garrote, F [1 ]
Cercenado, E [1 ]
Alcala, L [1 ]
Bouza, E [1 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Microbiol Serv, Madrid 28007, Spain
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1998年 / 42卷 / 09期
关键词：
D O I：
10.1128/AAC.42.9.2452
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The in vitro activity of LY333328 was compared with those of vancomycin and teicoplanin against 425 grampositive clinical isolates? including a variety of multiply resistant strains. LY333328 at less than or equal to 4 mu g/ml inhibited all microorganisms tested, including methicillin- and teicoplanin-resistant staphylococci, glycopeptide-resistant enterococci, penicillin- and multiply resistant pneumococci, and viridans and beta-hemolytic streptococci.
引用
收藏
页码：2452 / 2455
页数：4
相关论文
共 50 条
  • [1] Activity of a new glycopeptide antibiotic (LY333328) against enterococci and other resistant Gram-positive organisms
    Fraise, AP
    Andrews, J
    Wise, R
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (03) : 423 - 425
  • [2] The in-vitro activity of LY333328, a new glycopeptide, against clinical isolates of vancomycin-resistant enterococci
    Kirk, M
    Hill, RLR
    Casewell, MW
    Beighton, D
    [J]. STREPTOCOCCI AND THE HOST, 1997, 418 : 483 - 485
  • [3] In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates
    Cercenado, E
    García-Garrote, F
    Bouza, E
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (01) : 77 - 81
  • [4] In vitro activity of LY333328 (oritavancin) against Gram-positive aerobic cocci and synergy with ciprofloxacin against enterococci
    Noviello, S
    Ianniello, F
    Esposito, S
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (02) : 283 - 286
  • [5] In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide
    Biavasco, F
    Vignaroli, C
    Lupidi, R
    Manso, E
    Facinelli, B
    Varaldo, PE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (10) : 2165 - 2172
  • [6] In vitro activity of LY 333328 against anaerobic Gram-positive bacteria
    Sillerström, E
    Wahlund, E
    Nord, CE
    [J]. JOURNAL OF CHEMOTHERAPY, 1999, 11 (02) : 90 - 92
  • [7] In vitro activity of LY333328, a new glycopeptide, against extracellular and intracellular vancomycin-resistant enterococci
    Al-Nawas, B
    Swantes, J
    Shah, PM
    [J]. INFECTION, 2000, 28 (04) : 214 - 218
  • [8] In Vitro Activity of LY333328, a New Glycopeptide, against Extracellular and Intracellular Vancomycin-Resistant Enterococci
    B. Al-Nawas
    J. Swantes
    P. M. Shah
    [J]. Infection, 2000, 28 : 214 - 218
  • [9] In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci
    Schwalbe, RS
    McIntosh, AC
    Qaiyumi, S
    Johnson, JA
    Johnson, RJ
    Furness, KM
    Holloway, WJ
    SteeleMoore, L
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) : 2416 - 2419
  • [10] In vitro activity and spectrum of LY333328, a novel glycopeptide derivative
    Jones, RN
    Barret, MS
    Erwin, ME
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (02) : 488 - 493
12345